Cognitive decline in patients with Cushing's syndrome - PubMed (original) (raw)
Cognitive decline in patients with Cushing's syndrome
H Forget et al. J Int Neuropsychol Soc. 2000 Jan.
Abstract
Chronic exposure to elevated glucocorticoid levels in Cushing's syndrome (CS), is associated with deficits in cognitive function and in emotion. The hippocampus plays a crucial role in the behavioral manifestations of the syndrome as it is richest in glucocorticoid receptors and is thus particularly vulnerable to glucocorticoid excess. The wide distribution of glucocorticoid receptors throughout the cerebral cortex, however, suggests that several cognitive functions can also be affected by the dysregulation of glucocorticoids. In this study, we investigated how an excess of glucocorticoid hormones affects cognitive processes. Nineteen patients with chronic hypercortisolemia due to CS were compared to healthy controls matched for age, sex, education, and occupation in tests of processing of visual and spatial information, memory, reasoning and concept formation, language and verbal functions, and attention. Multivariate and univariate analyses revealed overall differences in tests of treatment of visual and spatial information, reasoning and concept formation as well as in verbal and language performance, with poorer performance from CS patients. Differences were also observed in nonverbal aspects of memory and in attention tasks. The results suggest that chronic exposure to elevated levels of cortisol is associated with deficits in several areas of cognition, particularly those involving processing of selective attention and visual components. This study also shows that hormones play an important role in the modulation of cognitive function and that their influence on cerebral structure and function merits closer scrutiny.
Similar articles
- Chronic glucocorticoid hypersecretion in Cushing's syndrome exacerbates cognitive aging.
Michaud K, Forget H, Cohen H. Michaud K, et al. Brain Cogn. 2009 Oct;71(1):1-8. doi: 10.1016/j.bandc.2009.02.013. Epub 2009 May 9. Brain Cogn. 2009. PMID: 19428166 - Long-term cognitive effects of glucocorticoid excess in Cushing's syndrome.
Forget H, Lacroix A, Bourdeau I, Cohen H. Forget H, et al. Psychoneuroendocrinology. 2016 Mar;65:26-33. doi: 10.1016/j.psyneuen.2015.11.020. Epub 2015 Nov 30. Psychoneuroendocrinology. 2016. PMID: 26708069 - A clinical profile of memory impairment in humans due to endogenous glucocorticoid excess.
León-Carrión J, Atutxa AM, Mangas MA, Soto-Moreno A, Pumar A, Leon-Justel A, Martín-Rodriguez JF, Venegas E, Domínguez-Morales MR, Leal-Cerro A. León-Carrión J, et al. Clin Endocrinol (Oxf). 2009 Feb;70(2):192-200. doi: 10.1111/j.1365-2265.2008.03355.x. Epub 2008 Aug 13. Clin Endocrinol (Oxf). 2009. PMID: 18702680 - Cushing's syndrome: update on signs, symptoms and biochemical screening.
Nieman LK. Nieman LK. Eur J Endocrinol. 2015 Oct;173(4):M33-8. doi: 10.1530/EJE-15-0464. Epub 2015 Jul 8. Eur J Endocrinol. 2015. PMID: 26156970 Free PMC article. Review. - Glucocorticoid excess and hypertension.
Baid S, Nieman LK. Baid S, et al. Curr Hypertens Rep. 2004 Dec;6(6):493-9. doi: 10.1007/s11906-004-0046-0. Curr Hypertens Rep. 2004. PMID: 15527696 Review.
Cited by
- Quality of life and other outcomes in children treated for Cushing syndrome.
Keil MF. Keil MF. J Clin Endocrinol Metab. 2013 Jul;98(7):2667-78. doi: 10.1210/jc.2013-1123. Epub 2013 May 2. J Clin Endocrinol Metab. 2013. PMID: 23640970 Free PMC article. Review. - An Interaction between Brain-Derived Neurotrophic Factor and Stress-Related Glucocorticoids in the Pathophysiology of Alzheimer's Disease.
Numakawa T, Kajihara R. Numakawa T, et al. Int J Mol Sci. 2024 Jan 27;25(3):1596. doi: 10.3390/ijms25031596. Int J Mol Sci. 2024. PMID: 38338875 Free PMC article. Review. - Psychiatric Symptoms in Patients with Cushing's Syndrome: Prevalence, Diagnosis and Management.
Santos A, Resmini E, Pascual JC, Crespo I, Webb SM. Santos A, et al. Drugs. 2017 May;77(8):829-842. doi: 10.1007/s40265-017-0735-z. Drugs. 2017. PMID: 28393326 Review. - Brain metabolite abnormalities in ventromedial prefrontal cortex are related to duration of hypercortisolism and anxiety in patients with Cushing's syndrome.
Crespo I, Santos A, Gómez-Ansón B, López-Mourelo O, Pires P, Vives-Gilabert Y, Webb SM, Resmini E. Crespo I, et al. Endocrine. 2016 Sep;53(3):848-56. doi: 10.1007/s12020-016-0963-0. Epub 2016 Apr 21. Endocrine. 2016. PMID: 27103571 - Cortical thickness abnormalities in long-term remitted Cushing's disease.
Bauduin SEEC, van der Pal Z, Pereira AM, Meijer OC, Giltay EJ, van der Wee NJA, van der Werff SJA. Bauduin SEEC, et al. Transl Psychiatry. 2020 Aug 21;10(1):293. doi: 10.1038/s41398-020-00980-6. Transl Psychiatry. 2020. PMID: 32826851 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical